Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: The optimal combination may be metformin, pioglitazone and empagliflozin
- Robert E.J. Ryder
- , Ralph A. Defronzo
Producción científica: Editorial › revisión exhaustiva
7
!!Link opens in a new tab
Citas
(Scopus)